TACROLIMUS GENOTYPING (CYP3A5)
The association between the CYP3A5 genotype and tacrolimus pharmacokinetics is well established, and patients expressing functional CYP3A5 (carriers of the CYP3A5*1 allele; extensive metabolizer), require approximately double the starting drug dose. Carriers of CYP3A5*3/*3 or poor metabolizer require higher doses.
Parameter(s) covered : 1
Report Frequency: Sample Mon through Sat by 10 am; Report Next day
Special Instruction: Physician prescription is mandatory.
Price : ₹ 5600.00
Parameters
- CYP3A5 GENOTYPE